Relation of Age, the Apolipoprotein B/Apolipoprotein A-I Ratio, and the Risk of Fatal Myocardial Infarction and Implications for the Primary Prevention of Cardiovascular Disease

American Journal of Cardiology

Volumn 100, Issue 2, 2007, Pages 217-221

  Sniderman, Allan D ^a   Holme, Ingar ^b   Aastveit, Are ^c   Furberg, Curt ^d   Walldius, Goran ^e,f   Jungner, Ingmar ^e,g  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f ASTRAZENECA R AND D   (Sweden)

^g CALAB Research   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B;

ADULT; AGE; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SWEDEN;

ADULT; AGE FACTORS; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 34447256301     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.02.086     Document Type: Article

References (14)

1. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
2. Jungner I., Marcovina S.M., Walldius G., Holme I., Kolar W., and Steiner E. Apolipoprotein B and A-I values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 44 (1998) 1641-1649
3. Jungner I., Walldius G., Holme I., Kolar W., and Steiner E. Apolipoprotein B and A-1 in relation to serum cholesterol and triglycerides in 43 600 males and females. J Lab Res 21 (1992) 247-255
4. Walldius G., Jungner I., Kolar W., Holme I., and Steiner E. High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction: first report from the AMORIS (Apolipoprotein-related Mortality Risk Study). Blood Press Suppl (1992) 35-42
5. Marcovina S.M., Albers J.J., Kennedy H., Mei J.V., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material. Clin Chem 40 (1994) 586-592
6. Marcovina S.M., Albers J.J., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clin Chem 39 (1993) 773-781
7. Conroy R.M., Pyorala K., Fitzgerald A.O., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetiere P., Jousilahti P., Keil U., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1103
8. Cook N.R., Buring J.E., and Ridker P.M. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145 (2006) 21-29
9. Briel M., Schwartz G.C., Thompson P.L., de Lemos J.A., Blazing M.A., van Es G.A., Kayikkcioglu M., Arntz H.R., den Hartog F.R., Veeger N.J., Colivicchi F., et al. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA 295 (2006) 2046-2056
10. Baigent C., Keech A., Kearney P.M., and Blackwell L. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data form 90 056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
11. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., and Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
12. Williams K., Sniderman A.D., Sattar N., D'Agostino Jr. R., Wagenknecht L.E., and Haffner S.M. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 108 (2003) 2312-2316
13. Lloyd-Jones D.M., Leip E.P., Larson M.G., D'Agostino R.B., Beiser A., Wilson P.W.F., Wolf P.A., and Levy D. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113 (2006) 791-798
14. Daviglus M.L., Liu K., Pirzada A., Yan L.L., Garside D.B., Feinglass J., Guralnik J.M., Greenland P., and Stamler J. Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Int Med 163 (2003) 2460-2468